|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Investments, at fair value | |||||||||||||||||
| Non-Controlled/Non-Affiliated Investments | |||||||||||||||||
| Non-Controlled Affiliated Investments | |||||||||||||||||
| Controlled Affiliated Investments | |||||||||||||||||
| Total investments, at fair value | |||||||||||||||||
| Investments in affiliated money market fund, Cost | |||||||||||||||||
| Cash | |||||||||||||||||
| Interest and dividends receivable | |||||||||||||||||
| Deferred financing costs | |||||||||||||||||
| Other assets | |||||||||||||||||
| Total assets | |||||||||||||||||
| Liabilities | |||||||||||||||||
| Debt (net of debt issuance costs of $11,187 and $8,169) | |||||||||||||||||
| Interest and other debt expenses payable | |||||||||||||||||
| Management fees payable | |||||||||||||||||
| Incentive fees payable | |||||||||||||||||
| Distribution payable | |||||||||||||||||
| Unrealized depreciation on derivatives | |||||||||||||||||
| Unrealized depreciation on foreign currency forward contracts | |||||||||||||||||
| Secured borrowings | |||||||||||||||||
| Accrued expenses and other liabilities | |||||||||||||||||
| Total liabilities | |||||||||||||||||
| Net assets | |||||||||||||||||
| Preferred stock, par value $0.001 per share (1,000,000 shares authorized, no shares issued and outstanding) | |||||||||||||||||
| Common stock, par value $0.001 per share (200,000,000 shares authorized, 111,049,130 and 112,569,067 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively) | |||||||||||||||||
| Paid-in capital in excess of par | |||||||||||||||||
| Distributable earnings (loss) | |||||||||||||||||
| Allocated income tax expense | |||||||||||||||||
| Total net assets | |||||||||||||||||
| Total liabilities and net assets | |||||||||||||||||
| Net asset value per share | |||||||||||||||||
Loading...